Open AccessTumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Author(s) -
Y.-P. Xu,
Lulu Lv,
Y. Liu,
M.D. Smith,
W.-C. Li,
Xiawei Tan,
Maryland Cheng,
Z. Li,
M. Bovino,
J. Aubé,
Yuquan Xiong
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1ybp-xc79
Subject(s) - suppressor , immunity , immunotherapy , cancer immunotherapy , cancer , medicine , immunology , cancer research , oncology , immune system